Since March 19, 2024, Iran’s biotechnology product exports have expanded to 35 countries, up from 33, showcasing the nation’s growing pharmaceutical biotechnology capabilities. Hossein Amirazodi, from the association of pharmaceutical biotechnology producers, reported these developments at the 4th International Conference on Iranian Medical Biotech Products. The industry saves Iran around $2 billion annually, constituting 60% of pharmaceutical exports, with Iran producing 40 of the 150 global biotechnology products. Additionally, medicine exports reached $104.6 million, a 19.7% increase, with 345 companies involved. Plans to boost pharmaceutical exports by 30% indicate potential growth in Iran’s biotechnology sector.